Frontlight ResearchEarly access
Active, not recruitingNo phase
MitraClip EXPAND G4 Study
Key facts
- Who runs it
- Abbott Medical Devices
- Where
- Albany, Austin, Birmingham, Charlotte, Cleveland, Evanston, Houston, La Jolla, Little Rock, Minneapolis, Mobile, Murray, Naples, Nashville, New York, Norfolk, Norwalk, Oklahoma City, Poughkeepsie, Sacramento, Springfield, Thousand Oaks, and Wichita, United StatesSee the 24 sitesAlso in 9 other countries, 39 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 1,164 people enrolled
- Started
- 17 Jan 2020
- Expected to end
- Mar 2028
- Type of study
- Observational
- Treatments tested
- MitraClip G4 System
- Record updated
- 11 July 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Subjects scheduled to receive the MitraClip per the current approved indications for use
- Subjects who give consent for their participation
Who cannot take part
- Subjects participating in another clinical study that may impact the follow-up or results of this study
Where in United States
Also in 9 other countries, 39 sites
- Albany Medical CenterAlbany, United States
- Austin HeartAustin, United States
- University of Alabama at BirminghamBirmingham, United States
- Carolinas Medical CenterCharlotte, United States
- The Cleveland Clinic FoundationCleveland, United States
- Northshore University Health SystemEvanston, United States
- Memorial Hermann HospitalHouston, United States
- Scripps HealthLa Jolla, United States
- Arkansas Heart HospitalLittle Rock, United States
- Abbott-Northwestern HospitalMinneapolis, United States
- Cardiology Associates of Mobile, Inc.Mobile, United States
- Intermountain Medical CenterMurray, United States
- NCH Healthcare SystemNaples, United States
- St. Thomas HospitalNashville, United States
- Mount Sinai HospitalNew York, United States
- NYU Langone HealthNew York, United States
- Sentara Norfolk General HospitalNorfolk, United States
- Cardiology Associates of Fairfield County, PCNorwalk, United States
- Integris Baptist Medical CenterOklahoma City, United States
- Hudson Valley Cardiovascular Practice, P.C.Poughkeepsie, United States
- University of California, Davis Medical CenterSacramento, United States
- Prairie Education & ResearchSpringfield, United States
- Los Robles Regional Medical CenterThousand Oaks, United States
- Via ChristiWichita, United States
About the trial
What the trial wants to find out
This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.
The group in the trial
- MitraClip G4 System
Percutaneous mitral valve repair using the MitraClip G4 system
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
- Publications
- Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation With Extended Non-COAPT-Like Features: From the EXPANDed Studies.JACC. Heart failure, 2025
- 1-Year Outcomes of Fourth-Generation Mitral Transcatheter Edge-to-Edge Repair in Japan From the EXPAND G4 Study.JACC. Asia, 2024
- 1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study.JACC. Cardiovascular interventions, 2023
- Record updated
- 11 July 2025